Arctic Light Venture Capital

Founded in 2005 by Mr. Deng Feng, Northern Light Venture Capital has long been dedicated to investing in promising early-stage, technology-driven companies, emphasizing the principles of "team, market, and innovation." The firm grows alongside its portfolio companies, managing total assets worth 30 billion yuan.

Bencao Capital

Bencao Capital is a specialized fund focused on the healthcare industry, investing in areas such as new drug development, medical devices, clinical diagnostics, and healthcare services.

Mint Angel Fund

The Mint Angel Fund is an early-stage venture capital fund focused on investing in and incubating technology-driven healthcare startups. With the mission of "building a bridge between R&D and commercialization, accelerating innovation and entrepreneurship in healthcare," the fund actively identifies and invests in entrepreneurial teams that possess cutting-edge platform technologies.

Boxin Capital

Boxin Capital focuses on equity investments and mergers & acquisitions in growth-stage and mature-stage companies poised for IPOs—sectors closely tied to China's rapid economic expansion. The firm currently manages a total fund size of nearly 9 billion yuan.

Chen De Capital

ChenDe Capital is an investment firm specializing in the life sciences and medical technology sectors, managing multiple USD-denominated and RMB-denominated funds with a total scale exceeding 4 billion RMB.

Chen Yi Investment

At the start of 2021, Chenyi Investment successfully closed fundraising for its first RMB-denominated M&A fund, reaching a total size of 6.8 billion yuan. Focusing on industries driven by structural transformation and innovative growth, Chenyi Investment is committed to long-term partnerships with companies that demonstrate strong growth potential, helping them thrive while continuously delivering value to investors and society.

Chi Xing Venture Capital

Established in 2016, Chixing Venture Capital was jointly launched by iFlytek and Yuanhe Mother Fund. Focused on intelligent interaction, the firm specializes in investing in early-stage projects within the AI industry. Its first-phase angel investment fund totals RMB 200 million, while the second-phase growth fund is set at RMB 1 billion.

Chuanliu Capital

Chuanliu Investment was established in 2016 and focuses on investments in the fields of new materials and chemical technology. Leveraging a combination of expert investment expertise, industry resources, and insightful market knowledge, we aim to identify high-growth investment opportunities. By driving fundamental growth through technological innovation, industrial upgrades, and enhanced societal value, we strive to deliver strong investment returns.

Dacheng Capital

Dattai Capital

Founded in 2010, Dattai Capital is a third-party, professional investment firm specializing in early-stage and growth-phase private equity investments. It currently manages multiple RMB- and USD-denominated funds.

Daotong Investment

Daotong Investment focuses on early-stage investments and industrial M&A in the greater healthcare sector, with a particular emphasis on medical services and innovative healthcare technologies.

DeLian Capital

Founded in 2011, Delian Capital focuses on technology-driven projects in sectors such as hard tech, cutting-edge technologies, and innovative healthcare.

DeTong Capital

DeTong Capital is a leading domestic private equity fund management company, specializing in investments across the TMT, consumer goods, healthcare, and advanced manufacturing sectors. Currently, the firm manages assets nearing 20 billion RMB.

Dingyi Investment

Founded in 2015, Dingyi Investment primarily focuses on investing in various distressed assets that emerge during China’s economic restructuring and industrial transformation and upgrading—opportunities that often arise as traditional industries evolve. The firm manages a total fund size nearing 10 billion RMB.

Fangguang Capital

Founded in 2012, Fangguang Capital specializes in identifying and nurturing international companies across the IT industry's upstream and downstream sectors. The firm primarily invests in technology-driven enterprises experiencing rapid growth, many of which have since become industry leaders while maintaining their momentum for sustained high-speed expansion.

Share the investment

Founded in 2007, Share Investment focuses on early-to-mid-stage investments across three key sectors: healthcare, consumer innovation, and cutting-edge technology. Currently, the firm manages assets exceeding RMB 8 billion.

Hillhouse Capital

Hillhouse Capital Group is a company focused on long-term, structurally driven value investing, with investments spanning sectors such as TMT, healthcare, consumer goods, and business services. It covers the entire spectrum of equity investments—ranging from early-stage seed funding and venture capital to private equity, public-listed company investments, and even mergers & acquisitions.

Gobi Ventures

Gobi Partners was founded in 2002 and is a leading venture capital firm in China, as well as the first domestically rooted VC firm to expand into Southeast Asia. With a globally oriented investment perspective, Gobi Partners manages multiple USD- and RMB-denominated funds.

National Innovation to Glory

Guochuang Zihui is positioned as a private equity investment fund focused on the real economy, with primary investments concentrated in four key sectors: high-end manufacturing, IoT communications, consumer-upgrade industries, and green/environmental protection initiatives. The fund targets high-value-added startups and growing enterprises within the industrial chain, primarily operating in the economically vibrant Yangtze River Delta region.

Guo Ke Jiahe

Founded in 2011, Guoke Jiahe Fund manages assets totaling hundreds of billions of RMB. The fund focuses on high-growth, high-tech industries with significant barriers to entry, including TMT and life sciences—emerging sectors where it strategically invests in areas such as IoT-driven intelligent manufacturing, semiconductors and IT, big data, cloud computing, artificial intelligence, fintech, and biopharmaceuticals.

Housheng Investment

Cambrian Venture Capital

Cambrian Ventures is a venture capital firm specializing in early-stage investments, dedicated to identifying top-tier entrepreneurial leaders across various industries in China. Since its establishment, the firm has invested in over 80 companies spanning sectors such as consumer goods, B2B, and education.

HanKang Capital

HanKang Capital (formerly Shanghai Jianxin Capital) was established in 2010 and is a venture capital firm specializing in China's biopharmaceutical industry, with a focus on addressing critical diseases and significant clinical needs.

Harley Capital

Founded in 2006, Heli Capital has managed New Taiwan Dollar funds, U.S. dollar funds, and RMB funds. Currently, it oversees the first-phase Integrated Circuit Industry Investment Fund, which primarily focuses on investing in high-end chips, advanced sensors, and system modules within the broader intelligent devices of industries such as artificial intelligence, the Internet of Things, and Industry 4.0—and is actively expanding its presence along the entire industry value chain.

Black Ant Capital

Black Ant Capital was founded in 2016 and is a professional investment firm specializing in the consumer sector. Committed to value discovery and creation, the firm employs a precise investment strategy to deliver impactful results.

Walden International

Founded in the U.S. in 1987, Walden International has grown into a globally recognized venture capital firm over the past three decades. The firm currently manages both USD-denominated and RMB-denominated funds, with total capital under management exceeding $2 billion.

Hua Sui Venture Capital

Huasui Venture Capital is a company that reinvests in foreign-invested enterprises, primarily focusing on investments in unlisted companies in China.

Hua Ying Capital

Founded in 2008, Huaying Capital is one of China's earliest private equity funds focused on the TMT and digital content sectors. Its investment portfolio spans digital entertainment, consumer upgrades, enterprise services, and technology, with assets under management exceeding RMB 7.5 billion.

Hua Capital Canada

Gene Capital

Gene Capital was established in 2014 as an RMB-denominated fund, primarily focusing on early-stage, growth-stage, and mature-stage innovative companies in the education sector.

GeekVenture Capital

Geekbang Ventures was founded in 2011 and focuses on early-stage investments in TMT sectors such as pan-entertainment, cloud technology, and smart hardware.

Jifeng Capital

Jifeng Capital is a healthcare investment firm founded in 2015, with total assets under management of approximately $1.27 billion. The firm is dedicated to investing in companies across the U.S. and China that boast exceptional management teams and ambitious visions, focusing on sectors such as biopharmaceuticals, medical devices, and medical diagnostics.

Jiayu Capital

Jiayu Capital was founded in 2011 and currently manages a total of approximately RMB 15 billion across its USD and RMB-denominated funds. The firm focuses on investing in sectors such as new consumer trends, cross-border e-commerce and global-brand expansion, technology-driven enterprise services, and cutting-edge technology innovations.

Bridge Capital

Founded in 2009, Jiaqiao Capital is a boutique private equity investment management firm specializing in the advanced manufacturing sector, with total assets under management exceeding 6.1 billion yuan.

Jiuhe Venture Capital

Founded in 2011, Jiuhe Venture Capital is an early-stage investment firm that has consistently focused on China's technology sector, excelling at identifying opportunities at the intersection of "Computing+" and in cross-disciplinary, cross-industry convergence areas.

Jinhe Capital

Jinhe Capital focuses on investments in the healthcare sector, with deep strategic deployments in areas such as in vitro diagnostics, innovative medical devices, and life sciences. Currently, the firm manages two healthcare-focused funds, totaling nearly 2 billion yuan in assets under management.

Jinshajiang Venture Capital

Founded in 2004, Jinsha River Venture Capital Fund specializes in early-stage investments, with a particular focus on AI-powered enterprise services, consumer internet, and healthcare technology. Jinsha River Venture Capital manages both USD and RMB funds, overseeing more than $3 billion in capital.

Jinshajiang Joint Investment

Jinshajiang United Capital is an RMB fund platform specializing in equity investments in the high-tech industry. It focuses on early-to-mid-stage innovative technology companies, particularly in areas such as general-purpose artificial intelligence (e.g., robotics, advanced manufacturing equipment, autonomous driving, and core components) and environmental protection technologies.

Junlian Capital

Junlian Capital focuses its core business on early-stage venture investments and growth-stage expansion capital, with a strong emphasis on innovation and growth opportunities in China. Currently, the firm manages USD and RMB funds totaling over 50 billion RMB.

Kunqiao Capital

Kunqiao Capital was founded in 2019 and focuses on investments in the semiconductor and technology sectors. The firm manages RMB-denominated private equity investment funds with assets under management exceeding 3.5 billion yuan.